Steve Schonfeld Schonfeld Strategic Advisors
Steve Schonfeld is the founder of Schonfeld Strategic Advisors, a multi-manager investment firm with roots in proprietary trading. Schonfeld allocates capital across quantitative and discretionary strategies with an emphasis on risk controls and diversification of return streams. The firm is a major name in the multi-strategy hedge fund landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
|
+$9.82M |
| 2 |
Dollar Tree
DLTR
|
+$8.78M |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$7.72M |
| 4 |
Elevance Health
ELV
|
+$7.55M |
| 5 |
Cigna
CI
|
+$7.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FDC
First Data Corporation
FDC
|
+$14.8M |
| 2 |
AET
Aetna Inc
AET
|
+$12.6M |
| 3 |
Merck
MRK
|
+$12.6M |
| 4 |
BRSL
Brightstar Lottery PLC
BRSL
|
+$12.6M |
| 5 |
Northrop Grumman
NOC
|
+$12M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 24.17% |
| 2 | Consumer Discretionary | 17.86% |
| 3 | Industrials | 12.79% |
| 4 | Financials | 9.03% |
| 5 | Technology | 7.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Mondelez International
MDLZ
$82.3B
| $5.82M | 0.48% |
+135,929
| New | +$5.71M |
|
52
Papa John's
PZZA
$788M
| $5.7M | 0.47% |
+101,542
| New | +$6.32M |
|
|
ABLX
53
DELISTED
Ablynx NV
ABLX
| $5.66M | 0.46% |
+226,275
| New | +$5.11M |
|
|
IMGN
54
DELISTED
Immunogen Inc
IMGN
| $5.55M | 0.45% |
865,356
-93,489
| -10% | -$577K |
|
55
Align Technology
ALGN
$11.5B
| $5.53M | 0.45% |
+24,896
| New | +$5.65M |
|
56
The Mosaic Company
MOS
$7.76B
| $5.53M | 0.45% |
+215,513
| New | +$4.95M |
|
|
PF
57
DELISTED
Pinnacle Foods, Inc.
PF
| $5.5M | 0.45% |
92,543
-17,155
| -16% | -$967K |
|
|
FISV
58
Fiserv Inc
FISV
$28B
| $5.5M | 0.45% |
+83,850
| New | +$5.41M |
|
59
Charles River Laboratories
CRL
$14.1B
| $5.49M | 0.45% |
50,125
+125
| +0.3% | +$13.6K |
|
60
Conagra Brands
CAG
$7.89B
| $5.47M | 0.45% |
145,321
+101,319
| +230% | +$3.6M |
|
|
KREF
61
KKR Real Estate Finance Trust
KREF
$487M
| $5.36M | 0.44% |
267,978
-30,437
| -10% | -$630K |
|
62
Regenxbio
RGNX
$708M
| $5.28M | 0.43% |
158,687
+18,567
| +13% | +$559K |
|
63
Constellium
CSTM
$3.66B
| $5.18M | 0.42% |
464,434
+356,558
| +331% | +$3.79M |
|
|
MGP
64
DELISTED
MGM Growth Properties LLC Class A common shares representing limited liability company interests
MGP
| $5.17M | 0.42% |
177,546
+65,159
| +58% | +$1.91M |
|
65
VF Corp
VFC
$5.65B
| $5.17M | 0.42% |
+74,220
| New | +$4.9M |
|
|
SIEN
66
DELISTED
Sientra, Inc.
SIEN
| $5.15M | 0.42% |
36,640
-130
| -0.4% | -$18.9K |
|
67
Cognex
CGNX
$10.2B
| $5.1M | 0.42% |
83,371
+28,425
| +52% | +$1.81M |
|
|
PVLA
68
Palvella Therapeutics
PVLA
$2.05B
| $5.1M | 0.42% |
8,438
-625
| -7% | -$291K |
|
69
American International
AIG
$39.8B
| $5.02M | 0.41% |
84,283
+29,468
| +54% | +$1.81M |
|
70
Sarepta Therapeutics
SRPT
$1.98B
| $5.01M | 0.41% |
90,000
-109,789
| -55% | -$5.82M |
|
71
AbbVie
ABBV
$468B
| $4.85M | 0.4% |
50,139
+41,139
| +457% | +$3.88M |
|
|
FLIR
72
DELISTED
FLIR Systems, Inc. (DE) Common Stock
FLIR
| $4.79M | 0.39% |
102,811
+96,908
| +1,642% | +$4.42M |
|
|
GPMT
73
Granite Point Mortgage Trust
GPMT
$54.5M
| $4.78M | 0.39% |
269,603
+49,321
| +22% | +$897K |
|
74
Tronox
TROX
$888M
| $4.71M | 0.39% |
+229,771
| New | +$5.6M |
|
|
CLVS
75
DELISTED
Clovis Oncology, Inc.
CLVS
| $4.71M | 0.39% |
69,240
+23,176
| +50% | +$1.62M |
|
Similar funds
Steve Schonfeld's Q4 2017 Portfolio in Review
As of Q4 2017, Steve Schonfeld held 998 positions worth $1.22B, up 12% from $1.1B the previous quarter. Its ten largest holdings account for 9.3% of the portfolio.
Steve Schonfeld deployed $160M of net new capital in Q4 2017, opening 433 new positions and adding to 145 existing holdings. Its largest new stake was State Street SPDR S&P MIDCAP 400 ETF Trust: 29,148 shares worth $10.1M.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 26% a quarter earlier, followed by Consumer Discretionary and Industrials.
On the sell side, the largest reduction was Aetna Inc, an estimated $12.6M trimmed.
- Steve Schonfeld's largest Q4 2017 buy was State Street SPDR S&P MIDCAP 400 ETF Trust: 29,148 shares worth $10.1M.
- Steve Schonfeld added most to Dollar Tree in Q4 2017, an estimated $8.78M increase.
- Steve Schonfeld's biggest Q4 2017 reduction was Aetna Inc, cutting an estimated $12.6M.
- Steve Schonfeld fully exited First Data Corporation in Q4 2017, selling an estimated $14.8M.
- Steve Schonfeld's ten largest holdings make up 9.3% of its $1.22B portfolio in Q4 2017.
- Steve Schonfeld opened 433 new positions and closed 273 in Q4 2017.
- Steve Schonfeld's portfolio value rose 12% quarter-over-quarter to $1.22B.
Based on Schonfeld Strategic Advisors's 13F filing for Q4 2017, filed 14 Feb 2018.